103 related articles for article (PubMed ID: 29371911)
1. TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration.
Schwartz AL; Dickerson E; Dagia N; Malgor R; McCall KD
Oncotarget; 2017 Dec; 8(69):113295-113302. PubMed ID: 29371911
[TBL] [Abstract][Full Text] [Related]
2. High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration.
McCall KD; Harii N; Lewis CJ; Malgor R; Kim WB; Saji M; Kohn AD; Moon RT; Kohn LD
Endocrinology; 2007 Sep; 148(9):4226-37. PubMed ID: 17525119
[TBL] [Abstract][Full Text] [Related]
3. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of LPS-induced TLR4 signaling products in murine macrophages by phenylmethimazole: an assay methodology for screening potential phenylmethimazole analogs.
Deosarkar SP; Bhatt P; Gillespie J; Goetz DJ; McCall KD
Drug Dev Res; 2014 Dec; 75(8):497-509. PubMed ID: 25408546
[TBL] [Abstract][Full Text] [Related]
5. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
[TBL] [Abstract][Full Text] [Related]
6. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
7. The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.
S P N; Darvin P; Yoo YB; Joung YH; Kang DY; Kim DN; Hwang TS; Kim SY; Kim WS; Lee HK; Cho BW; Kim HS; Park KD; Park JH; Chang SH; Yang YM
BMC Cancer; 2015 Jun; 15():474. PubMed ID: 26084564
[TBL] [Abstract][Full Text] [Related]
8. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
10. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis.
Harii N; Lewis CJ; Vasko V; McCall K; Benavides-Peralta U; Sun X; Ringel MD; Saji M; Giuliani C; Napolitano G; Goetz DJ; Kohn LD
Mol Endocrinol; 2005 May; 19(5):1231-50. PubMed ID: 15661832
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
12. Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
Treeck O; Wackwitz B; Haus U; Ortmann O
Gynecol Oncol; 2006 Aug; 102(2):292-9. PubMed ID: 16443261
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.
Cover CM; Hsieh SJ; Cram EJ; Hong C; Riby JE; Bjeldanes LF; Firestone GL
Cancer Res; 1999 Mar; 59(6):1244-51. PubMed ID: 10096555
[TBL] [Abstract][Full Text] [Related]
14. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Salaun B; Lebecque S; Matikainen S; Rimoldi D; Romero P
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4565-74. PubMed ID: 17671143
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
18. STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells.
Yi EH; Lee CS; Lee JK; Lee YJ; Shin MK; Cho CH; Kang KW; Lee JW; Han W; Noh DY; Kim YN; Cho IH; Ye SK
Mol Cancer Res; 2013 Jan; 11(1):31-42. PubMed ID: 23074171
[TBL] [Abstract][Full Text] [Related]
19. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
20. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]